

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.58659027 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.32990984 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.88947445 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.75639338 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.64255298 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.63335638 |
| 7 | vocalization behavior (GO:0071625) | 5.48143974 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.38495368 |
| 9 | glutamate secretion (GO:0014047) | 5.33678002 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.24863023 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.10537711 |
| 12 | cerebellar granule cell differentiation (GO:0021707) | 5.08694847 |
| 13 | protein localization to synapse (GO:0035418) | 5.01758502 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.84782536 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.71217648 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.70043595 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.50215939 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 4.46004519 |
| 19 | exploration behavior (GO:0035640) | 4.39079603 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.38390073 |
| 21 | sodium ion export (GO:0071436) | 4.34354031 |
| 22 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.28314276 |
| 23 | amino acid import (GO:0043090) | 4.27150793 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21228328 |
| 25 | regulation of synapse maturation (GO:0090128) | 4.20016439 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.19297921 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.17949994 |
| 28 | neuron cell-cell adhesion (GO:0007158) | 4.14834000 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 4.09500795 |
| 30 | neuronal ion channel clustering (GO:0045161) | 4.09284063 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 4.08621072 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 4.07183407 |
| 33 | central nervous system myelination (GO:0022010) | 4.03017122 |
| 34 | axon ensheathment in central nervous system (GO:0032291) | 4.03017122 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 4.02991137 |
| 36 | positive regulation of dendritic spine development (GO:0060999) | 3.99935003 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.99353741 |
| 38 | neurotransmitter transport (GO:0006836) | 3.97415852 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.96337419 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.96051747 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 3.91906758 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.91804966 |
| 43 | long-term memory (GO:0007616) | 3.91465935 |
| 44 | retinal cone cell development (GO:0046549) | 3.84692661 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.83506012 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.82901693 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.77885391 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.77494087 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.76053837 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.75035409 |
| 51 | proline transport (GO:0015824) | 3.74421425 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.68754909 |
| 53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.67101475 |
| 54 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.66333190 |
| 55 | glycine transport (GO:0015816) | 3.63723921 |
| 56 | neuromuscular process controlling posture (GO:0050884) | 3.63676956 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.63074755 |
| 58 | cell communication by electrical coupling (GO:0010644) | 3.55516914 |
| 59 | membrane hyperpolarization (GO:0060081) | 3.54425293 |
| 60 | regulation of neurotransmitter levels (GO:0001505) | 3.52766693 |
| 61 | positive regulation of neurotransmitter transport (GO:0051590) | 3.48218406 |
| 62 | regulation of synaptic plasticity (GO:0048167) | 3.44430969 |
| 63 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.43935778 |
| 64 | activation of protein kinase A activity (GO:0034199) | 3.42865096 |
| 65 | neurotransmitter uptake (GO:0001504) | 3.42351245 |
| 66 | L-amino acid import (GO:0043092) | 3.41623372 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.39488272 |
| 68 | regulation of vesicle fusion (GO:0031338) | 3.37091227 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36208822 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.35951542 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 3.35506552 |
| 72 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.33554011 |
| 73 | innervation (GO:0060384) | 3.32328102 |
| 74 | dendritic spine organization (GO:0097061) | 3.30828932 |
| 75 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.29201544 |
| 76 | regulation of dendritic spine development (GO:0060998) | 3.29031664 |
| 77 | neuromuscular process controlling balance (GO:0050885) | 3.28463263 |
| 78 | cell differentiation in hindbrain (GO:0021533) | 3.28455221 |
| 79 | transmission of nerve impulse (GO:0019226) | 3.28283485 |
| 80 | * regulation of ARF protein signal transduction (GO:0032012) | 3.27901998 |
| 81 | membrane depolarization during action potential (GO:0086010) | 3.27123193 |
| 82 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26431242 |
| 83 | neuron recognition (GO:0008038) | 3.26318573 |
| 84 | potassium ion homeostasis (GO:0055075) | 3.26203496 |
| 85 | response to pheromone (GO:0019236) | 3.25301988 |
| 86 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.24224094 |
| 87 | acidic amino acid transport (GO:0015800) | 3.22905580 |
| 88 | response to histamine (GO:0034776) | 3.22475384 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21668281 |
| 90 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.21642398 |
| 91 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.21103771 |
| 92 | vesicle docking involved in exocytosis (GO:0006904) | 3.20461605 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 3.16867729 |
| 94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.16805005 |
| 95 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.16358772 |
| 96 | membrane depolarization (GO:0051899) | 3.14759043 |
| 97 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13469808 |
| 98 | response to auditory stimulus (GO:0010996) | 3.13451379 |
| 99 | regulation of exocytosis (GO:0017157) | 3.12702544 |
| 100 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.12654066 |
| 101 | potassium ion import (GO:0010107) | 3.11867009 |
| 102 | signal release (GO:0023061) | 3.11709618 |
| 103 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.10836459 |
| 104 | detection of calcium ion (GO:0005513) | 3.09902458 |
| 105 | prepulse inhibition (GO:0060134) | 3.09604308 |
| 106 | dendrite morphogenesis (GO:0048813) | 3.09253043 |
| 107 | establishment of synaptic vesicle localization (GO:0097480) | 3.08902332 |
| 108 | synaptic vesicle transport (GO:0048489) | 3.08902332 |
| 109 | postsynaptic membrane organization (GO:0001941) | 3.06419823 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 3.04870582 |
| 111 | learning (GO:0007612) | 3.03602195 |
| 112 | cellular sodium ion homeostasis (GO:0006883) | 3.03274283 |
| 113 | synaptic transmission (GO:0007268) | 3.03218658 |
| 114 | chemosensory behavior (GO:0007635) | 3.02880469 |
| 115 | intraspecies interaction between organisms (GO:0051703) | 3.02110267 |
| 116 | social behavior (GO:0035176) | 3.02110267 |
| 117 | auditory behavior (GO:0031223) | 3.01980739 |
| 118 | establishment of mitochondrion localization (GO:0051654) | 3.00896632 |
| 119 | behavioral fear response (GO:0001662) | 2.98960886 |
| 120 | behavioral defense response (GO:0002209) | 2.98960886 |
| 121 | neuromuscular process (GO:0050905) | 2.98663751 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97670798 |
| 123 | axonal fasciculation (GO:0007413) | 2.96062592 |
| 124 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.95834530 |
| 125 | regulation of synaptic transmission (GO:0050804) | 2.95691182 |
| 126 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94780085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.79712968 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.46461957 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03850857 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00481354 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97469091 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83245652 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.78439167 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.72060910 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.72060910 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65244576 |
| 11 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59407832 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55351267 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53865697 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.50937547 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50280573 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48792559 |
| 17 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41530612 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35339077 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33787105 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.32684351 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31230424 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.22396316 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19438674 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18244695 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16925565 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.07690066 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97485554 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96817893 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93419757 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87577553 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87421577 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69283362 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60794094 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59421699 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55877476 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47155681 |
| 37 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39772009 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39491682 |
| 39 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37827646 |
| 40 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.30003016 |
| 41 | AR_19668381_ChIP-Seq_PC3_Human | 1.29424056 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28451200 |
| 43 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27503972 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26416353 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26018012 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24799609 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.24204784 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23279481 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22831269 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22213297 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21837273 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20921007 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19964269 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19963952 |
| 55 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19794663 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19449903 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17839612 |
| 58 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17812192 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16627270 |
| 60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16571890 |
| 61 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15438876 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14205056 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13868832 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13257240 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13160224 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12788703 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10827846 |
| 68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10487368 |
| 69 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.09692900 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06867296 |
| 71 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06122632 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05888327 |
| 73 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05600690 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05514592 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04880003 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03989295 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03896805 |
| 78 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02989059 |
| 79 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02286803 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02249342 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01464323 |
| 82 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99276138 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99262125 |
| 84 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98849633 |
| 85 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98456189 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98124081 |
| 87 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.98107930 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97859095 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97805532 |
| 90 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97793224 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97286373 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96229740 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96198399 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96065379 |
| 95 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93509899 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93417426 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92736572 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92387550 |
| 99 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.92203375 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91752241 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91664373 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90691391 |
| 103 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.89934012 |
| 104 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89674600 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89468034 |
| 106 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88926778 |
| 107 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87986717 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87481760 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86303334 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85038845 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85038845 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84902297 |
| 113 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83003717 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82759328 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82685840 |
| 116 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82284495 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81972167 |
| 118 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.81899070 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81705372 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78708111 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 0.78411801 |
| 122 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78304346 |
| 123 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.77687992 |
| 124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77320632 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76712781 |
| 126 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.76569716 |
| 127 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.75378092 |
| 128 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.74207440 |
| 129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71906705 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70483537 |
| 131 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.68891370 |
| 132 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.67283489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.41369175 |
| 2 | MP0003880_abnormal_central_pattern | 4.77084742 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.07386693 |
| 4 | MP0004270_analgesia | 3.51780318 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.46194260 |
| 6 | MP0009745_abnormal_behavioral_response | 3.29567353 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.19805062 |
| 8 | MP0002064_seizures | 3.16801264 |
| 9 | MP0009046_muscle_twitch | 3.10904225 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.91364819 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.83917223 |
| 12 | MP0001486_abnormal_startle_reflex | 2.71749930 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.66480909 |
| 14 | MP0002272_abnormal_nervous_system | 2.61623723 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.58985595 |
| 16 | MP0002822_catalepsy | 2.42480880 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.28421261 |
| 18 | MP0002736_abnormal_nociception_after | 2.00329875 |
| 19 | MP0008569_lethality_at_weaning | 1.96296723 |
| 20 | MP0002067_abnormal_sensory_capabilities | 1.94699445 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.93843676 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.90584286 |
| 23 | MP0001970_abnormal_pain_threshold | 1.83532309 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.78472586 |
| 25 | MP0006072_abnormal_retinal_apoptosis | 1.78381844 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.77825802 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.74019188 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.73944411 |
| 29 | MP0002184_abnormal_innervation | 1.71722234 |
| 30 | MP0001984_abnormal_olfaction | 1.67885865 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.67343202 |
| 32 | MP0005253_abnormal_eye_physiology | 1.65708697 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.64405513 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.63628341 |
| 35 | MP0004924_abnormal_behavior | 1.63628341 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.62736564 |
| 37 | MP0004858_abnormal_nervous_system | 1.62316693 |
| 38 | MP0004885_abnormal_endolymph | 1.61009648 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.60783676 |
| 40 | MP0000778_abnormal_nervous_system | 1.59462820 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.59180522 |
| 42 | MP0002090_abnormal_vision | 1.58962122 |
| 43 | MP0003123_paternal_imprinting | 1.56775651 |
| 44 | MP0003329_amyloid_beta_deposits | 1.56372007 |
| 45 | MP0000955_abnormal_spinal_cord | 1.51969473 |
| 46 | MP0003879_abnormal_hair_cell | 1.46898139 |
| 47 | MP0003787_abnormal_imprinting | 1.46216377 |
| 48 | MP0002229_neurodegeneration | 1.45570115 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.39392952 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.38115402 |
| 51 | MP0004142_abnormal_muscle_tone | 1.31773403 |
| 52 | MP0003633_abnormal_nervous_system | 1.31577846 |
| 53 | MP0003122_maternal_imprinting | 1.31070680 |
| 54 | MP0004147_increased_porphyrin_level | 1.22603901 |
| 55 | MP0000751_myopathy | 1.12986824 |
| 56 | MP0003011_delayed_dark_adaptation | 1.12726673 |
| 57 | MP0003631_nervous_system_phenotype | 1.09441160 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.09087369 |
| 59 | MP0002752_abnormal_somatic_nervous | 1.08714498 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.07643480 |
| 61 | MP0001905_abnormal_dopamine_level | 1.06611810 |
| 62 | MP0002152_abnormal_brain_morphology | 1.06289504 |
| 63 | MP0004233_abnormal_muscle_weight | 1.05320203 |
| 64 | MP0008872_abnormal_physiological_respon | 1.02735599 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.01337001 |
| 66 | MP0005195_abnormal_posterior_eye | 0.97881801 |
| 67 | MP0001529_abnormal_vocalization | 0.97366115 |
| 68 | MP0001177_atelectasis | 0.96418249 |
| 69 | MP0008961_abnormal_basal_metabolism | 0.96361203 |
| 70 | MP0001986_abnormal_taste_sensitivity | 0.94621346 |
| 71 | MP0003634_abnormal_glial_cell | 0.93533726 |
| 72 | MP0010386_abnormal_urinary_bladder | 0.93449503 |
| 73 | MP0003690_abnormal_glial_cell | 0.92762298 |
| 74 | MP0002069_abnormal_eating/drinking_beha | 0.91492096 |
| 75 | MP0005394_taste/olfaction_phenotype | 0.90988597 |
| 76 | MP0005499_abnormal_olfactory_system | 0.90988597 |
| 77 | MP0001348_abnormal_lacrimal_gland | 0.90494690 |
| 78 | MP0004742_abnormal_vestibular_system | 0.88662444 |
| 79 | MP0001188_hyperpigmentation | 0.86621813 |
| 80 | MP0003075_altered_response_to | 0.86157378 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.84672921 |
| 82 | MP0004085_abnormal_heartbeat | 0.84113321 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.82368815 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.79911527 |
| 85 | MP0004215_abnormal_myocardial_fiber | 0.78264377 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.77503943 |
| 87 | MP0003632_abnormal_nervous_system | 0.77271567 |
| 88 | MP0008874_decreased_physiological_sensi | 0.75970390 |
| 89 | MP0003283_abnormal_digestive_organ | 0.75272926 |
| 90 | MP0000920_abnormal_myelination | 0.74566355 |
| 91 | MP0005535_abnormal_body_temperature | 0.74191053 |
| 92 | MP0001346_abnormal_lacrimal_gland | 0.73204538 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.73078147 |
| 94 | MP0004130_abnormal_muscle_cell | 0.72355645 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.68633955 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.61296565 |
| 97 | MP0003121_genomic_imprinting | 0.60253100 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.60236005 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.58883170 |
| 100 | MP0000604_amyloidosis | 0.57629748 |
| 101 | MP0005409_darkened_coat_color | 0.57451989 |
| 102 | MP0001664_abnormal_digestion | 0.55705349 |
| 103 | MP0004043_abnormal_pH_regulation | 0.55483170 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.54859513 |
| 105 | MP0010769_abnormal_survival | 0.54057196 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.52721066 |
| 107 | MP0001943_abnormal_respiration | 0.52210541 |
| 108 | MP0010768_mortality/aging | 0.51886447 |
| 109 | MP0001324_abnormal_eye_pigmentation | 0.51855704 |
| 110 | MP0010770_preweaning_lethality | 0.51368238 |
| 111 | MP0002082_postnatal_lethality | 0.51368238 |
| 112 | MP0003956_abnormal_body_size | 0.51250402 |
| 113 | MP0003045_fibrosis | 0.47468455 |
| 114 | MP0005166_decreased_susceptibility_to | 0.46480740 |
| 115 | MP0004510_myositis | 0.45499127 |
| 116 | MP0002873_normal_phenotype | 0.43778395 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.43327507 |
| 118 | MP0005448_abnormal_energy_balance | 0.43058588 |
| 119 | MP0002169_no_abnormal_phenotype | 0.42247076 |
| 120 | MP0000026_abnormal_inner_ear | 0.40711846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.81352421 |
| 2 | Myokymia (HP:0002411) | 6.61187845 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.53850781 |
| 4 | Focal seizures (HP:0007359) | 5.22846378 |
| 5 | Visual hallucinations (HP:0002367) | 5.08215039 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.82546384 |
| 7 | Febrile seizures (HP:0002373) | 4.77245432 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.58847192 |
| 9 | Atonic seizures (HP:0010819) | 4.01595587 |
| 10 | Central scotoma (HP:0000603) | 4.00974879 |
| 11 | Absence seizures (HP:0002121) | 3.95141713 |
| 12 | Dyschromatopsia (HP:0007641) | 3.92913436 |
| 13 | Action tremor (HP:0002345) | 3.91366908 |
| 14 | Abnormality of macular pigmentation (HP:0008002) | 3.77853995 |
| 15 | Obstructive sleep apnea (HP:0002870) | 3.77437717 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.74476903 |
| 17 | Cerebral hypomyelination (HP:0006808) | 3.68383071 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.63477958 |
| 19 | Dialeptic seizures (HP:0011146) | 3.53298871 |
| 20 | Tetraplegia (HP:0002445) | 3.52299999 |
| 21 | Ankle clonus (HP:0011448) | 3.45133992 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.37986814 |
| 23 | Depression (HP:0000716) | 3.30991268 |
| 24 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.25602081 |
| 25 | Broad-based gait (HP:0002136) | 3.19866982 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.16880686 |
| 27 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.12920060 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.12381314 |
| 29 | Mutism (HP:0002300) | 3.12224048 |
| 30 | Postural instability (HP:0002172) | 3.11242452 |
| 31 | Truncal ataxia (HP:0002078) | 3.09717342 |
| 32 | Genetic anticipation (HP:0003743) | 3.08182870 |
| 33 | Scotoma (HP:0000575) | 3.03115823 |
| 34 | Delusions (HP:0000746) | 3.02516683 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00179420 |
| 36 | Dysmetria (HP:0001310) | 3.00035437 |
| 37 | Poor eye contact (HP:0000817) | 2.98546340 |
| 38 | Decreased central vision (HP:0007663) | 2.96953711 |
| 39 | Akinesia (HP:0002304) | 2.93335627 |
| 40 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.92983897 |
| 41 | Anxiety (HP:0000739) | 2.87133513 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.86907705 |
| 43 | Abnormal eating behavior (HP:0100738) | 2.84210489 |
| 44 | Ventricular fibrillation (HP:0001663) | 2.81239855 |
| 45 | Abnormality of the lower motor neuron (HP:0002366) | 2.78047996 |
| 46 | Abnormal social behavior (HP:0012433) | 2.77177332 |
| 47 | Impaired social interactions (HP:0000735) | 2.77177332 |
| 48 | Sleep apnea (HP:0010535) | 2.76890017 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.69417355 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.68585952 |
| 51 | Scanning speech (HP:0002168) | 2.64418183 |
| 52 | Hemiplegia (HP:0002301) | 2.58399190 |
| 53 | Papilledema (HP:0001085) | 2.58105649 |
| 54 | Apathy (HP:0000741) | 2.55034505 |
| 55 | Hemiparesis (HP:0001269) | 2.52437921 |
| 56 | Rigidity (HP:0002063) | 2.51331779 |
| 57 | Urinary urgency (HP:0000012) | 2.51004117 |
| 58 | Amblyopia (HP:0000646) | 2.50094067 |
| 59 | Hyperventilation (HP:0002883) | 2.47913972 |
| 60 | Peripheral hypomyelination (HP:0007182) | 2.47733120 |
| 61 | Intention tremor (HP:0002080) | 2.47129078 |
| 62 | Spastic gait (HP:0002064) | 2.45381140 |
| 63 | Torticollis (HP:0000473) | 2.44342231 |
| 64 | Excessive salivation (HP:0003781) | 2.43155873 |
| 65 | Drooling (HP:0002307) | 2.43155873 |
| 66 | Severe visual impairment (HP:0001141) | 2.40965161 |
| 67 | Choreoathetosis (HP:0001266) | 2.40531070 |
| 68 | Bradykinesia (HP:0002067) | 2.40525734 |
| 69 | Spastic tetraparesis (HP:0001285) | 2.39254118 |
| 70 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.39099438 |
| 71 | Diminished motivation (HP:0000745) | 2.31163091 |
| 72 | Progressive inability to walk (HP:0002505) | 2.27052452 |
| 73 | CNS hypomyelination (HP:0003429) | 2.26422163 |
| 74 | Dysmetric saccades (HP:0000641) | 2.22289570 |
| 75 | Focal dystonia (HP:0004373) | 2.21075599 |
| 76 | Increased circulating renin level (HP:0000848) | 2.20711069 |
| 77 | Rapidly progressive (HP:0003678) | 2.18617962 |
| 78 | Pheochromocytoma (HP:0002666) | 2.15817356 |
| 79 | Insomnia (HP:0100785) | 2.15215606 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.14376289 |
| 81 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13011528 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.12646783 |
| 83 | Diplopia (HP:0000651) | 2.12411805 |
| 84 | Abnormality of binocular vision (HP:0011514) | 2.12411805 |
| 85 | Stereotypic behavior (HP:0000733) | 2.12026442 |
| 86 | Absent speech (HP:0001344) | 2.11970746 |
| 87 | Lower limb asymmetry (HP:0100559) | 2.11655984 |
| 88 | Status epilepticus (HP:0002133) | 2.10649070 |
| 89 | Choroideremia (HP:0001139) | 2.10628476 |
| 90 | Lower limb muscle weakness (HP:0007340) | 2.06677223 |
| 91 | Spinal canal stenosis (HP:0003416) | 2.06474404 |
| 92 | Abnormal EKG (HP:0003115) | 2.06221888 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05510276 |
| 94 | Impaired vibratory sensation (HP:0002495) | 2.04948503 |
| 95 | Pendular nystagmus (HP:0012043) | 2.02547136 |
| 96 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01491874 |
| 97 | Megalencephaly (HP:0001355) | 2.01119378 |
| 98 | Attenuation of retinal blood vessels (HP:0007843) | 2.01093977 |
| 99 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99574020 |
| 100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99574020 |
| 101 | Pigmentary retinal degeneration (HP:0001146) | 1.97617691 |
| 102 | Bundle branch block (HP:0011710) | 1.96218294 |
| 103 | Neurofibrillary tangles (HP:0002185) | 1.96041353 |
| 104 | Craniofacial dystonia (HP:0012179) | 1.95603617 |
| 105 | Agitation (HP:0000713) | 1.94754660 |
| 106 | Pointed chin (HP:0000307) | 1.94599150 |
| 107 | Polyphagia (HP:0002591) | 1.94408550 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 1.94306892 |
| 109 | Prolonged QT interval (HP:0001657) | 1.93121743 |
| 110 | Photophobia (HP:0000613) | 1.91912035 |
| 111 | Hypsarrhythmia (HP:0002521) | 1.89766743 |
| 112 | Clonus (HP:0002169) | 1.86405840 |
| 113 | Type II diabetes mellitus (HP:0005978) | 1.85324447 |
| 114 | Abnormality of saccadic eye movements (HP:0000570) | 1.83471397 |
| 115 | Hypoventilation (HP:0002791) | 1.83203235 |
| 116 | Annular pancreas (HP:0001734) | 1.83125388 |
| 117 | Gait imbalance (HP:0002141) | 1.82478503 |
| 118 | Limb dystonia (HP:0002451) | 1.82112315 |
| 119 | Unsteady gait (HP:0002317) | 1.81966296 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 1.79816655 |
| 121 | Memory impairment (HP:0002354) | 1.79036325 |
| 122 | Gait ataxia (HP:0002066) | 1.78048854 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.76891648 |
| 124 | Neuroendocrine neoplasm (HP:0100634) | 1.76384905 |
| 125 | Incomplete penetrance (HP:0003829) | 1.76239377 |
| 126 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75860265 |
| 127 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75706787 |
| 128 | Heart block (HP:0012722) | 1.72449748 |
| 129 | Slow progression (HP:0003677) | 1.71066763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.50211808 |
| 2 | EPHA4 | 3.85972814 |
| 3 | MAP3K9 | 3.82371671 |
| 4 | MAP3K4 | 3.09654321 |
| 5 | MARK1 | 2.97654725 |
| 6 | MINK1 | 2.79237005 |
| 7 | PAK6 | 2.60914421 |
| 8 | MAP2K7 | 2.52564305 |
| 9 | PRKD3 | 2.35280588 |
| 10 | NTRK2 | 2.34452271 |
| 11 | DAPK2 | 2.32527692 |
| 12 | CAMKK1 | 2.01092389 |
| 13 | STK38 | 1.94793136 |
| 14 | MAP2K4 | 1.88632342 |
| 15 | MAP3K12 | 1.87399613 |
| 16 | PRPF4B | 1.73836542 |
| 17 | KSR2 | 1.72374551 |
| 18 | NTRK1 | 1.68754776 |
| 19 | CDK5 | 1.60013888 |
| 20 | TNIK | 1.52783118 |
| 21 | SIK2 | 1.50696475 |
| 22 | GRK5 | 1.37727078 |
| 23 | RIPK4 | 1.37612472 |
| 24 | KSR1 | 1.37609940 |
| 25 | DAPK1 | 1.34036010 |
| 26 | UHMK1 | 1.29980511 |
| 27 | MAPK13 | 1.29638706 |
| 28 | CASK | 1.25940365 |
| 29 | PLK2 | 1.25920132 |
| 30 | CDK19 | 1.24339661 |
| 31 | FES | 1.23749024 |
| 32 | PRKCG | 1.23199139 |
| 33 | PINK1 | 1.18488940 |
| 34 | PNCK | 1.15097753 |
| 35 | CAMK1 | 1.13711537 |
| 36 | PHKG2 | 1.13605541 |
| 37 | PHKG1 | 1.13605541 |
| 38 | SGK223 | 1.07477547 |
| 39 | SGK494 | 1.07477547 |
| 40 | TYRO3 | 0.99438910 |
| 41 | STK11 | 0.98445566 |
| 42 | PRKCH | 0.98154613 |
| 43 | MAP3K13 | 0.97804255 |
| 44 | CDK18 | 0.97278353 |
| 45 | TNK2 | 0.96987268 |
| 46 | CDK15 | 0.96650380 |
| 47 | TAOK1 | 0.95274942 |
| 48 | CAMK2A | 0.95104300 |
| 49 | ARAF | 0.91943987 |
| 50 | SGK2 | 0.90831648 |
| 51 | ALK | 0.90494411 |
| 52 | CDK14 | 0.89749697 |
| 53 | MAP3K2 | 0.89366080 |
| 54 | CAMKK2 | 0.88880042 |
| 55 | DYRK1A | 0.88656935 |
| 56 | CDK11A | 0.84880654 |
| 57 | LMTK2 | 0.83722128 |
| 58 | SGK3 | 0.82371095 |
| 59 | LATS2 | 0.81920486 |
| 60 | PAK3 | 0.78943498 |
| 61 | MARK2 | 0.78413690 |
| 62 | NEK1 | 0.77588251 |
| 63 | CAMK1G | 0.77123701 |
| 64 | MAP3K11 | 0.75797880 |
| 65 | GRK1 | 0.73255267 |
| 66 | RET | 0.72242441 |
| 67 | WNK1 | 0.72109945 |
| 68 | SGK1 | 0.71685427 |
| 69 | PKN1 | 0.70706543 |
| 70 | MAP3K7 | 0.69114933 |
| 71 | CAMK2B | 0.67920112 |
| 72 | DAPK3 | 0.66452222 |
| 73 | RIPK1 | 0.62992367 |
| 74 | CDC42BPA | 0.62935141 |
| 75 | FGFR2 | 0.61998829 |
| 76 | RPS6KA3 | 0.60093098 |
| 77 | PDK1 | 0.59607579 |
| 78 | OXSR1 | 0.57544186 |
| 79 | PRKCZ | 0.57433712 |
| 80 | MAPK10 | 0.56877535 |
| 81 | CAMK4 | 0.56514009 |
| 82 | CSNK1G2 | 0.55362154 |
| 83 | NEK6 | 0.54833940 |
| 84 | CAMK2D | 0.54182314 |
| 85 | RAF1 | 0.52332885 |
| 86 | PDPK1 | 0.49716142 |
| 87 | MAP3K1 | 0.49520605 |
| 88 | PTK2B | 0.49391942 |
| 89 | PRKG2 | 0.47781894 |
| 90 | BRAF | 0.46939374 |
| 91 | TAOK2 | 0.46101975 |
| 92 | CAMK2G | 0.45549393 |
| 93 | BRSK1 | 0.45343644 |
| 94 | LIMK1 | 0.45013691 |
| 95 | FYN | 0.43909896 |
| 96 | PRKCE | 0.41672497 |
| 97 | PRKCB | 0.40727163 |
| 98 | MAP2K6 | 0.40044931 |
| 99 | NME1 | 0.40008803 |
| 100 | BMPR2 | 0.39807408 |
| 101 | SIK3 | 0.39462153 |
| 102 | WNK3 | 0.39390304 |
| 103 | TESK1 | 0.37771505 |
| 104 | FER | 0.37388075 |
| 105 | SCYL2 | 0.36625876 |
| 106 | ROCK2 | 0.34675673 |
| 107 | PRKCA | 0.33187431 |
| 108 | RPS6KA2 | 0.32178178 |
| 109 | MAPKAPK5 | 0.31148327 |
| 110 | MAPK12 | 0.31106430 |
| 111 | ROCK1 | 0.29746575 |
| 112 | IRAK2 | 0.28464917 |
| 113 | PRKG1 | 0.27828209 |
| 114 | MAPK8 | 0.26954116 |
| 115 | ERBB2 | 0.26733095 |
| 116 | JAK2 | 0.26662949 |
| 117 | PRKACA | 0.25106199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.75066477 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.59897974 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.56027736 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.93677512 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.81955985 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.69242553 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64813370 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.57523405 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54842858 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.30533749 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27097929 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.16053277 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.10502772 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07092091 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.05445774 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94043618 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83008016 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78639577 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66448249 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62789348 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58726435 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.57002384 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.53807153 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51734377 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49474564 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.44773124 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44309191 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.43779529 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43134056 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42580740 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41401536 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32950101 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25706176 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22255421 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20319507 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19583169 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.18426545 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14459800 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10373738 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03173533 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01577548 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.00061971 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98213778 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97058385 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 0.94565897 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92969132 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91870464 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.86390211 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84750683 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82974094 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81582168 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80099941 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77287154 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76224628 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74162187 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72171695 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71741172 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70545939 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69354615 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65062956 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64771206 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62334943 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58595346 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58179388 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56656580 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56441425 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.56235348 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55186069 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54205806 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53268558 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52891113 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51041068 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50961733 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48023755 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.47684909 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47434243 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46954020 |
| 78 | * Endocytosis_Homo sapiens_hsa04144 | 0.46568768 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45570694 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45384260 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45052435 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43654781 |
| 83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43276491 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42666740 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41589119 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40241762 |
| 87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39899810 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37852990 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36853072 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36659178 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35769556 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34048732 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33734353 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33080848 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32650431 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31205411 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30966384 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.30473568 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30164019 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29303997 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.28844350 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28784113 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27641800 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26616379 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24753100 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24600655 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24483233 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.22275967 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19948856 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15216548 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.13810363 |

